You are required to be logged in to access the full website
Click here if you have forgotten your username or password
10 August 2026 - Spanish pharmaceutical company Almirall S.A. (BME:ALM) said on Monday that it has entered into a collaboration and licensing agreement with Shenzhen CrystalO Biopharma Technology Co Ltd to discover and develop novel small molecules f...
10 August 2026 - Biopharmaceutical company Swedish Orphan Biovitrum AB (Sobi) (STO:SOBI) and clinical-stage biotechnology company Innate Pharma SA (Euronext Paris:IPH) (Nasdaq:IPHA) announced on Monday that they have entered into a strategic partners...
10 August 2026 - Clinical-stage biopharmaceutical company Saniona AB (STO:SANION) announced on Monday that biotechnology company AstronauTx Ltd has exercised its option to acquire exclusive worldwide rights to research, develop, manufacture and comme...
10 August 2026 - Switzerland-based biopharmaceutical company Oculis Holding AG (NASDAQ:OCS) (XICE:OCS) announced on Monday that it has entered into an asset purchase agreement with Accure Therapeutics S.L., a private translational neuroscience R&...
10 August 2026 - Clinical-stage biotechnology company Biophytis SA (Euronext Growth Paris:ALBPS) (OTC:BPTSY) announced on Monday that it has received approval from Brazil's National Health Surveillance Agency (ANVISA) to begin its Phase 2 OBA cl...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe